dihexa pharmacology EllieMD Dihexa (PNB-0408) | c-Met/HGFR Activator
Description
doi: 10.1016/0092-8674(88)90562-4
V.LeeH.KumbhaniR.Siwila-SackmanE.McKayE
The 2023 impact of inflammatory bowel disease in Canada: access to and models of care
- Other less frequently reported side effects include hot flushes, dizziness and nausea
If the committee votes to move a peptide to the 503A Bulks List, that peptide becomes legally compoundable on a patient-specific Rx basis
